Submitted by Anonymous (not verified) on 24 October 2023 - 8:22
Human medicines European public assessment report (EPAR): Prolia, denosumab, Bone Resorption;Osteoporosis, Postmenopausal, Date of authorisation: 26/05/2010, Revision: 27, Status: Authorised
Source: